Douglas W. Loe, analyst for Leede Jones Gable, reviewed the latest news from Theratechnologies in an update to clients on Monday and reiterated a “Speculative Buy” rating on the stock.
Leede Jones Gable analyst Douglas W. Loe reviewed on Wednesday the latest quarterly results from Theratechnologies and reiterated a “Speculative Buy” rating on the stock.